The 20 Best Diffuse Midline Glioma H3 K27M-Mutant Doctors in The United States

Eric Raabe, M.D., Ph.D., is an associate professor of oncology and pathology at Johns Hopkins School of Medicine. Dr. Raabe majored in neural science at Brown University and received his M.D. and Ph.D. from the University of Cincinnati College of Medicine. He completed his pediatric internship and residency at Children’s Hospital of Philadelphia. After spending a year working in Africa as part of the Baylor International Pediatric AIDS Initiative, Dr. Raabe joined Johns Hopkins as a pediatric oncology fellow. Working in the laboratory of Charles Eberhart in Neuropathology, Dr. Raabe established a neural stem cell system to create genetically accurate models of pediatric brain tumors. In collaboration with patients and families, he has also developed multiple pediatric brain tumor cell lines that are some of the key models used for pre-clinical testing. Dr. Raabe sees patients in the pediatric oncology outpatient clinic at Johns Hopkins, with a focus on pediatric brain tumors. Dr. Raabe is also the point person in oncology for retinoblastoma care. He continues his research in the new Smith Building of the Wilmer Eye Institute in the Neuropathology Division, in collaboration with Charles Eberhart. Dr. Raabe is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Rhabdoid Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Glioma, and Pediatric Low-Grade Glioma (pLGG). Dr. Raabe is board certified in American Board Of Pediatrics.

Dr. Koschmann is a Pediatric Neuro-Oncologist in the Department of Pediatrics and a Principal Investigator of an independent translational Pediatric Neuro-Oncology laboratory. His work in the clinic and lab complement and drive each other, resulting in a clear goal to improve therapies for children with brain tumors. He has engaged in research and the clinical care of pediatric brain tumor patients at both Seattle Children’s Hospital and the University of Michigan’s Mott Children’s Hospital. The Koschmann laboratory is exploring the molecular mechanisms by which recurrent mutations in pediatric high-grade glioma (HGG), including glioblastoma (GBM), anaplastic astrocytoma (AA) and diffuse intrinsic pontine glioma (DIPG) promotes tumor formation and affect treatment response.Dr. Koschmann has applied this precision medicine approach in translational and clinical work in Pediatric Neuro-Oncology. Along with researchers and colleagues from multiple clinical divisions at the University of Michigan and other institutions, he developed and co-facilitate the UM CNS Precision Medicine conference. In this multi-disciplinary and multi-institutional conference, molecular results are incorporated from pediatric brain tumor patients (paired tumor/germline sequencing results and pre-clinical cell culture treatment studies) into their treatment. Dr. Koschmann has established new algorithms and are in the process of developing multiple clinical trials incorporating the use of molecularly targeted therapy for pediatric patients with brain tumors. He will serve as PI for these trials and their biologic correlative research. Dr. Koschmann is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Brain Stem Cancer, and Embryonal Tumor with Multilayered Rosettes. Dr. Koschmann is board certified in Pediatric Hematology-Oncology and Pediatrics.

Alberto Broniscer is a Hematologist and an Oncologist practicing medicine in Memphis, Tennessee. Dr. Broniscer is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, Glioma, and Medulloblastoma.

Mark Souweidane is a Neurosurgery provider practicing medicine in Brooklyn, New York. Dr. Souweidane is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Brain Tumor, Gliomatosis Cerebri, Craniopharyngioma, and Osteotomy. Dr. Souweidane is board certified in American Board Of Pediatric Neurological Surgery and American Board Of Neurological Surgery. Dr. Souweidane is currently accepting new patients.

Michelle Monje is a Neurologist practicing medicine in Palo Alto, California. Dr. Monje is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Brain Stem Cancer, and Gliomatosis Cerebri.

Oren Becher is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Becher is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Brain Stem Cancer, and Medulloblastoma.

Maryam Fouladi is a Hematologist and an Oncologist practicing medicine in Columbus, Ohio. Dr. Fouladi is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Medulloblastoma, and Brain Stem Cancer.

Roger Packer is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Packer is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Neurofibromatosis, and Gliomatosis Cerebri.

Nicholas Vitanza is a Hematologist and an Oncologist practicing medicine in Seattle, Washington. Dr. Vitanza is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, Glioma, and Medulloblastoma.

Ira Dunkel is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Dunkel is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, and Glioma. Dr. Dunkel is currently accepting new patients.

Cassie Kline is a Hematologist and an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Kline is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Brain Stem Cancer, and Medulloblastoma.

Anthony Asher is a Neurosurgery provider practicing medicine in Charlotte, North Carolina. Dr. Asher is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Spondylolisthesis, Cervical Myelopathy, Brain Tumor, Laminectomy, and Spinal Fusion. Dr. Asher is board certified in American Board Of Neurological Surgery. Dr. Asher is currently accepting new patients.

Nina Paleologos is a Psychiatrist and a Neurologist practicing medicine in Downers Grove, Illinois. Dr. Paleologos is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Oligodendroglioma, Glioma, Glioblastoma, and Astrocytoma. Dr. Paleologos is board certified in American Board Of Psychiatry & Neurology.

David Gass is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Gass is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Infantile Neutropenia, Brain Stem Cancer, and Glioma. Dr. Gass is board certified in American Board Of Pediatrics. Dr. Gass is currently accepting new patients.

Dr. Joseph Quillin believes that the practice of neurosurgery is a tremendous privilege. His focus is on durable symptom relief, patient quality of life, maximum safe tumor resection, and the prevention of further neurological damage for his patients. His advanced training in brain, spine, and skull base/cerebrovascular disorders has enabled him to care for some of the most complex patients in neurosurgery. Dr. Quillin specializes in neurosurgical oncology and skull base surgery, using techniques such as radiotherapy and minimally invasive endoscopic surgery to promote tumor treatment and removal. He has served the DFW area since 2021.Dr. Quillin earned his medical degree at Louisiana State University Health Sciences Center in Shreveport. He completed his neurological surgery residency and fellowship training in neurological oncology at Emory University in Atlanta, Georgia. He also completed additional fellowship training in skull base/cerebrovascular surgery at Rutgers University in New Brunswick, N.J. Away from the office, Dr. Quillin has served as an ad hoc reviewer for publications including NEUROSURGERY, World Neurosurgery, and the Journal of Neuro-Oncology. He is a member of the American Association of Neurological Surgeons and Congress of Neurological Surgeons. Dr. Quillin is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Meningioma, Pituitary Tumor, Chiari Malformation Type 1, Endoscopic Transnasal Transsphenoidal Surgery, and Awake Craniotomy.

Daphne Li is a Neurosurgery provider practicing medicine in Park Ridge, Illinois. Dr. Li is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Hydrocephalus, Mosaic Trisomy 9, Glomus Jugulare Tumor, Thrombectomy, and Osteotomy. Dr. Li is board certified in  .

Ian Pollack, MD, is Chief of Pediatric Neurosurgery at UPMC Children’s Hospital of Pittsburgh, A. Leland Albright Professor of Neurosurgery, and vice-chair for Academic Affairs at the University of Pittsburgh School of Medicine. He is professor of clinical and translational science and distinguished professor of neurosurgery at the University of Pittsburgh. Dr. Pollack is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Glioma, Gliomatosis Cerebri, Brain Tumor, Posterior Fossa Decompression, and Craniectomy. Dr. Pollack is board certified in American Board Of Neurological Surgery.

Bryan Buster is a Neurosurgery provider practicing medicine in Gainesville, Georgia. Dr. Buster is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His clinical expertise encompasses Hydrocephalus, Intraventricular Hemorrhage of the Newborn, Thrombophlebitis, and Brain Stem Cancer. Dr. Buster is currently accepting new patients.

. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Pulmonary Edema, Thrombectomy, and Laminectomy. Dr. Shah is board certified in American Osteopathic Board Of Internal Medicine.

Dr. Patricia Robertson, M.D., earned a medical degree at Wayne State University Medical School in Detroit and completed a residency in pediatrics at Children's Hospital of Michigan. She then went on to a fellowship in pediatric neurology at the University of Michigan and trained in pediatric neuro-oncology at New York University Medical Center. Dr. Robertson joined the University of Michigan faculty in 1988. She has a special interest in clinical pediatric neuro-oncology focusing on the evaluation of response, outcome and late effects on the developing nervous system; current treatment strategies for children with central nervous malignancies; and in the development of innovative treatment approaches for this population. Dr. Robertson is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Glioma, Diencephalic Syndrome, Brain Stem Cancer, and Brain Tumor.